Welcome to LookChem.com Sign In|Join Free

CAS

  • or

102065-88-3

Acetamide, N-3-azetidinyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

102065-88-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 102065-88-3 Structure

  • Basic information

    1. Product Name: Acetamide, N-3-azetidinyl-
    2. Synonyms: 3-acetylamino-1-azetidine
    3. CAS NO:102065-88-3
    4. Molecular Formula: C5H10N2O
    5. Molecular Weight: 114.1472
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 102065-88-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Acetamide, N-3-azetidinyl-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Acetamide, N-3-azetidinyl-(102065-88-3)
    11. EPA Substance Registry System: Acetamide, N-3-azetidinyl-(102065-88-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 102065-88-3(Hazardous Substances Data)

102065-88-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 102065-88-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,0,6 and 5 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 102065-88:
(8*1)+(7*0)+(6*2)+(5*0)+(4*6)+(3*5)+(2*8)+(1*8)=83
83 % 10 = 3
So 102065-88-3 is a valid CAS Registry Number.

102065-88-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-acetylamino-1-azetidine

1.2 Other means of identification

Product number -
Other names N-Azetidin-3-yl-acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102065-88-3 SDS

102065-88-3Relevant articles and documents

NOVEL TETRAHYDROPYRIDOPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HBV INFECTION

-

Page/Page column 148; 149, (2018/09/25)

The present invention provides novel compounds having general formula (I), wherein R1 to R4, A, W, Q and Y are as described herein, compositions including the compounds and methods of using the compounds.

Anti-inflammatory agents

-

Page/Page column 56; 57; 122; 123, (2016/02/05)

Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.

2-SUBSTITUTED-ETHYNYLTHIAZOLE DERIVATIVES AND USES OF SAME

-

Page/Page column 17, (2011/05/03)

The present invention provides 2-substituted-ethynylthiazole derivatives of formula (I): wherein R1, R2 and X are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods of using same.

Thiophene derivatives useful as anticancer agents

-

, (2008/06/13)

The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt and to pharmaceutically acceptable salts and hydrates thereof, wherein X, Y, R1, R2 and R11 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102065-88-3